TRANSGENE BIOTEK LTD. Share Price

₹ 2.57

+₹0.24 (10.30%)
1D
Last updated 02 Nov, 2026, 15:29 IST

TRANSGENE BIOTEK LTD. Share Price Today

As of 3 Nov 2026, TRANSGENE BIOTEK LTD. share price is ₹2.57. The stock opened at ₹2.38, compared to its previous close of ₹2.33. During today's trading session, TRANSGENE BIOTEK LTD. share price moved in the range of ₹2.29 to ₹2.57, with an average price of ₹2.43 for the day. Looking at its last 52-week, the stock has touched a low of ₹1.83 and a high of ₹4.19.

Share price over the last 1 day rose from 2.37 to 2.57, ranging between 2.29 and 2.57.
₹2.29
10.30% up today
₹2.57
1D LOW
1D HIGH

TRANSGENE BIOTEK LTD. Stock Insights

Latest Earning
Op Profit TrendUp by 15.22% QoQ
Latest Earning
Net Profit TrendUp by 15.22% QoQ
Latest Earning
Revenue TrendDown by 70.00% QoQ
Stock Performance
UnderperformingUnderperforming Nifty by 28.16 % in last 1 yr
TRANSGENE BIOTEK LTD. stock performance
Open₹2.38
High₹2.57
Low₹2.29
Prev. close₹2.33
TRANSGENE BIOTEK LTD. trading activity
Volume21,872
Average traded price₹2.35
Last traded time03:29:56 02 Nov
Last traded quantity328
Circuit
L
H
₹1.96
₹2.94
52-week
L
H
₹1.83
₹4.19
Mkt Cap Cr
17.65
P/E
-11.1
P/B
2.11
ROA
-1.12%
ROE
-19.73%
ROCE
-2.32%
EV/EBITDA
-112.02

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Transgene Biotek has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Transgene Biotek appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Transgene Biotek earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEEV/EBITDA
Apollo Hospitals1,20,779.1155.6112.749.79%20.48%17.27%30.42
Manipal Health Enterprises Limited87,926.3994.845.234.07%10.59%9.51%34.66
Max Healthcare83,704.6860.657.397.37%12.18%13.24%33.68
Aster DM Healthcare58,742.01164.2814.164.47%8.48%10.1%66.59
Fortis Healthcare58,116.6853.65.86.7%10.53%12.56%28.03
Narayana Hrudayalaya35,143.9343.047.746.43%17.17%12.26%19.68
Global Health34,121.9063.238.819.35%14.05%15.26%32.32
Dr. Lal Path Labs31,997.0258.5712.7617.36%20.13%25.56%34.28
KRISHNA INST OF MED SCI L29,480.26155.698.082.51%10.74%7.99%39.1
Syngene International16,251.7287.333.342.79%5.47%7.06%22.34

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

TRANSGENE BIOTEK LTD. Company Background

ISIN
INE773D01018
Sector Market Cap
₹ 17.65 Cr

Transgene Biotek Limited is an India-based biotechnology company. It is engaged in the research and development of vaccines, oncology, and new drug delivery technologies. Its portfolio of products includes oncology, autoimmunity, drug delivery and biogenetics. The Company offers TrabiAAV, which is a platform for the delivery of micro-ribonucleic acids (miRNAs), short hairpin RNA (ShRNAs), immunogens developing clinical significance in gene therapy and CRISPR/cas 9 technologies. Its monoclonal antibody therapy is the use of monoclonal antibodies to specifically bind to target cells. Its TrabiORAL drug is focused on delivering proteins and peptides orally for a variety of human diseases. Its TBL-1203 drug is used to strengthen cell-mediated immunity and complete the elimination of the human immunodeficiency virus (HIV), without any need for retroviral drug therapy. Its Tacrolimus drug suppresses the immune system and is mainly used to prevent rejection of transplanted organs.

TRANSGENE BIOTEK LTD. Financial Highlights

  • Revenue: TRANSGENE BIOTEK LTD. reported revenue of ₹0.36 crore in FY26 vs ₹1.04 crore in FY25. It showed a decrease of 65.38% on a yearly basis.
  • Operating Profit: TRANSGENE BIOTEK LTD. reported an operating loss of ₹1.65 crore in FY26 vs ₹0.68 crore in FY25. It showed a decrease of 142.65% on a year-on-year basis.
  • Net Profit: TRANSGENE BIOTEK LTD. reported a net loss of ₹1.65 crore in FY26 vs ₹0.68 crore in FY25. It showed a decrease of 142.65% on a yearly basis.

TRANSGENE BIOTEK LTD. Quarterly Result Highlights

  • TRANSGENE BIOTEK LTD. reported revenue of ₹0.06 crore in Jun 2026, compared with ₹0.20 crore in Mar 2026, representing a decrease of 70.00% on a quarter-on-quarter (QoQ) basis.
  • TRANSGENE BIOTEK LTD. reported an operating loss of ₹0.39 crore in Jun 2026, compared with ₹0.46 crore in Mar 2026, representing an increase of 15.22% on a quarter-on-quarter (QoQ) basis.
  • TRANSGENE BIOTEK LTD. reported a loss of ₹0.39 crore in Jun 2026, compared with ₹0.46 crore in Mar 2026, reflecting an increase of 15.22% on a QoQ basis.
  • The earnings per share (EPS) of TRANSGENE BIOTEK LTD. stood at ₹0.09 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
23.64%
FII
0.00%
Other DII
0.00%
Retail and other
76.36%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

TRANSGENE BIOTEK LTD. Investment Returns

1 day
+5.15%
1 week
--
1 month
+2.08%
1 year
-35.19%
3 years
-42.08%
5 years
-37.66%

TRANSGENE BIOTEK LTD. Share Price History

TRANSGENE BIOTEK LTD. share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹2.38 / ₹2.45
+5.15%
30 Oct 26
₹2.59 / ₹2.33
-3.72%
29 Oct 26
₹2.41 / ₹2.42
+2.54%
28 Oct 26
₹2.37 / ₹2.36
-2.48%
Show more

TRANSGENE BIOTEK LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹0.26₹0.23₹0.06₹0.09
Other Income₹0.78₹0.18₹0.18₹0.21
Total Revenue₹1.04₹0.42₹0.23₹0.30
Total Expenses₹1.72₹1.07₹6.24₹10.70
Profit Before Tax-₹0.68-₹0.66-₹6.01-₹10.40
Tax₹0.00₹0.00₹0.00₹0.00
Profit After Tax-₹0.68-₹0.66-₹6.01-₹10.40
EPS - Basic-₹0.09-₹0.09-₹0.79-₹1.37
EPS - Diluted-₹0.09-₹0.09-₹0.79-₹1.37

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹0.68-₹0.66-₹6.01-₹10.40
Income before WC changes-₹0.52-₹0.61-₹1.05-₹0.43
Change in Assets₹0.12-₹0.06-₹0.13-₹0.05
Change in Liabilities₹1.60₹0.67₹1.18₹0.58
Change in WC₹1.72₹0.61₹1.05₹0.52
Cash flow from Operations₹1.20₹0.00₹0.00₹0.10
Cash flow from Investing-₹1.70₹0.00-₹0.01-₹0.10
Cash flow from Financing₹0.78₹0.00₹0.00₹0.00
Total Cash Flow₹0.28₹0.00-₹0.01₹0.00
Cash (Start of the year)₹0.01₹0.00₹0.02₹0.01
Cash (End of the year)₹0.28₹0.01₹0.00₹0.02

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹142.83₹141.22₹141.31₹146.40
Current Assets₹1.26₹1.11₹1.04₹0.70
Total Assets₹144.09₹142.33₹142.36₹147.10
Current Liabilities₹12.74₹11.14₹10.47₹9.21
Net Current Asset-₹11.47-₹10.03-₹9.42-₹8.51
Non-Current Liabilities₹121.32₹120.48₹120.52₹120.52
Equity Capital₹10.03₹10.71₹11.37₹17.38
Total Equity & Liabilities₹144.09₹142.33₹142.36₹147.10

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹0.26₹0.23₹0.06₹0.09
Other Income₹0.78₹0.18₹0.18₹0.21
Total Revenue₹1.04₹0.42₹0.23₹0.30
Total Expenses₹1.72₹1.07₹6.24₹10.70
Profit Before Tax-₹0.68-₹0.66-₹6.01-₹10.40
Tax₹0.00₹0.00₹0.00₹0.00
Profit After Tax-₹0.68-₹0.66-₹6.01-₹10.40
EPS - Basic-₹0.09-₹0.09-₹0.79-₹1.37
EPS - Diluted-₹0.09-₹0.09-₹0.79-₹1.37

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹0.68-₹0.66-₹6.01-₹10.40
Income before WC changes-₹0.52-₹0.61-₹1.05-₹0.43
Change in Assets₹0.12-₹0.06-₹0.13-₹0.05
Change in Liabilities₹1.59₹0.67₹1.18₹0.58
Change in WC₹1.71₹0.61₹1.05₹0.52
Cash flow from Operations₹1.20₹0.00₹0.00₹0.10
Cash flow from Investing-₹1.70₹0.00-₹0.01-₹0.10
Cash flow from Financing₹0.78₹0.00₹0.00₹0.00
Total Cash Flow₹0.28₹0.00-₹0.01₹0.00
Cash (Start of the year)₹0.01₹0.00₹0.02₹0.01
Cash (End of the year)₹0.28₹0.01₹0.00₹0.02

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹32.95₹31.34₹31.44₹36.53
Current Assets₹1.26₹1.10₹1.04₹0.69
Total Assets₹34.20₹32.44₹32.48₹37.22
Current Liabilities₹12.63₹11.04₹10.36₹9.10
Net Current Asset-₹11.37-₹9.93-₹9.33-₹8.41
Non-Current Liabilities₹29.12₹28.28₹28.32₹28.32
Equity Capital-₹7.55-₹6.87-₹6.21-₹0.20
Total Equity & Liabilities₹34.20₹32.44₹32.48₹37.22
* All values are in INR Crore
TRANSGENE BIOTEK LTD. market depth
Bid quantityBid priceAsk priceAsk quantity
002.4592
0000
0000
0000
0000
Total bid quantity0
Total ask quantity92
TRANSGENE BIOTEK LTD. technical summary
Bearish indicators1
Neutral indicators6
Bullish indicators1
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
47.28
Neutral
ATR (14)
0.31
Neutral
STOCH(9,6)
37.04
Neutral
STOCH RSI (14)
62.14
Neutral
ADX(9)
17.07
Bullish
UO(9)
32.42
Neutral
ROC(12)
-7.2
Bearish
WillR(14)
-62.96
Neutral
Period
Simple value
Exponential vaue
5D
2.4
2.41
10D
2.43
2.43
20D
2.46
2.48
50D
2.63
2.6
100D
2.81
2.71
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

TRANSGENE BIOTEK LTD.
Healthcare Services
Add Stock
Add Another

TRANSGENE BIOTEK LTD. Returns Calculator

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

TRANSGENE BIOTEK LTD. Share Price FAQs

Please be aware that TRANSGENE BIOTEK LTD. stock prices are subject to continuous fluctuations due to various factors.